BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27219844)

  • 1. Protein-Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery.
    Milhas S; Raux B; Betzi S; Derviaux C; Roche P; Restouin A; Basse MJ; Rebuffet E; Lugari A; Badol M; Kashyap R; Lissitzky JC; Eydoux C; Hamon V; Gourdel ME; Combes S; Zimmermann P; Aurrand-Lions M; Roux T; Rogers C; Müller S; Knapp S; Trinquet E; Collette Y; Guillemot JC; Morelli X
    ACS Chem Biol; 2016 Aug; 11(8):2140-8. PubMed ID: 27219844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning.
    Shimizu Y; Yonezawa T; Sakamoto J; Furuya T; Osawa M; Ikeda K
    Sci Rep; 2021 Apr; 11(1):7420. PubMed ID: 33795749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database.
    Bourgeas R; Basse MJ; Morelli X; Roche P
    PLoS One; 2010 Mar; 5(3):e9598. PubMed ID: 20231898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods.
    Reynès C; Host H; Camproux AC; Laconde G; Leroux F; Mazars A; Deprez B; Fahraeus R; Villoutreix BO; Sperandio O
    PLoS Comput Biol; 2010 Mar; 6(3):e1000695. PubMed ID: 20221258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space.
    Zhang X; Betzi S; Morelli X; Roche P
    Future Med Chem; 2014 Jul; 6(11):1291-307. PubMed ID: 24773599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical libraries dedicated to protein-protein interactions].
    Sperandio O; Villoutreix BO; Morelli X; Roche P
    Med Sci (Paris); 2015 Mar; 31(3):312-9. PubMed ID: 25855285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
    Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
    J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Compound Classes: Protein-Protein Interactions.
    Ottmann C
    Handb Exp Pharmacol; 2016; 232():125-38. PubMed ID: 26489828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the druggability of protein-protein interactions by a supervised machine-learning method.
    Sugaya N; Ikeda K
    BMC Bioinformatics; 2009 Aug; 10():263. PubMed ID: 19703312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine.
    Hamon V; Bourgeas R; Ducrot P; Theret I; Xuereb L; Basse MJ; Brunel JM; Combes S; Morelli X; Roche P
    J R Soc Interface; 2014 Jan; 11(90):20130860. PubMed ID: 24196694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Privileged Substructures to Modulate Protein-Protein Interactions.
    Bosc N; Kuenemann MA; Bécot J; Vavrusa M; Cerdan AH; Sperandio O
    J Chem Inf Model; 2017 Oct; 57(10):2448-2462. PubMed ID: 28922596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the chemical space of protein-protein interaction inhibitors through machine learning.
    Choi J; Yun JS; Song H; Kim NH; Kim HS; Yook JI
    Sci Rep; 2021 Jun; 11(1):13369. PubMed ID: 34183730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fr-PPIChem: An Academic Compound Library Dedicated to Protein-Protein Interactions.
    Bosc N; Muller C; Hoffer L; Lagorce D; Bourg S; Derviaux C; Gourdel ME; Rain JC; Miller TW; Villoutreix BO; Miteva MA; Bonnet P; Morelli X; Sperandio O; Roche P
    ACS Chem Biol; 2020 Jun; 15(6):1566-1574. PubMed ID: 32320205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a rule-based method for the assessment of protein druggability.
    Perola E; Herman L; Weiss J
    J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.